|
Article ID: 697551 Alzheimer's Drug Discovery FoundationPhilanthropist Bill Gates and the Alzheimer's Drug Discovery Foundation (ADDF) co-founder Leonard Lauder have announced a new initiative, Diagnostics Accelerator, to develop novel biomarkers for the early detection of Alzheimer's disease and related dementias. |
Article ID: 697431 University of California, Los Angeles (UCLA), Health SciencesMolecular tracer combined with PET scans show locations and concentrations of abnormal proteins associated with degenerative brain disease |
|
Article ID: 697466 Keck Medicine of USCThe Keck School of Medicine of USC is leading a $26.5 million effort to conduct the first large-scale, multi-institutional study on African-American men with prostate cancer. Channels: Behavioral Science, Cancer, Men's Health, Mental Health, Neuro, Psychology and Psychiatry, Local - California, Local - LA Metro African American Men, Prostate Cancer, Keck School Of Medicine Of Usc, USC, National Cancer Insitute, National Institute on Minority Health and Health Disparities, Prostate Cancer Foundation, Grant, genetics and cancer, Cancer, Aggressive Prostate Cancer, socioeconomic factors, Stress |
Article ID: 697517 American Association of Neurological Surgeons (AANS)Mayfield Brain & Spine joins over 100 existing QOD participating centers. |
|
Article ID: 697493 Florida Atlantic UniversityResearchers are working on this collaborative project that utilizes genomic and transgenic technology in Mexican cavefish to identify genetic loci that contribute to sleep, feeding, and metabolism. |
|
Article ID: 697481 Johns Hopkins MedicineA Johns Hopkins Medicine analysis of information gathered for an ongoing and federally sponsored study of aging and disability adds to evidence that a substantial majority of older adults with probable dementia in the United States have never been professionally diagnosed or are unaware they have been. |
|
Article ID: 697503 Lawrence Livermore National LaboratoryA new study in which Lawrence Livermore National Laboratory scientists compared drug responses in the brains of rodents to drug responses of brain cells cultured in Lab-developed “brain-on-a-chip” devices may be a critical first step to validating chip-based brain platforms, LLNL researchers said. |
Article ID: 697423 Washington University in St. LouisNew research led by Washington University School of Medicine in St. Louis indicates an investigational therapy for an inherited form of ALS extends survival and reverses signs of neuromuscular damage in mice and rats. The findings, published July 16 in The Journal of Clinical Investigation, have led to a phase one/two clinical trial to investigate whether the drug could benefit people with ALS whose disease is caused by mutations in a gene called SOD1. |
|
Article ID: 697465 Family Institute at Northwestern UniversityNonsuicidal self-injury (NSSI) refers to deliberate, socially unacceptable destruction of one’s own body tissue performed without the intention to die |
Embargo will expire:18-Jul-2018 1:00 AM EDTReleased to reporters:16-Jul-2018 9:00 AM EDT |